| Application no. and date | 07867297.9 (espacenet) (Federated) (European Patent Register), 20071030 | | Patent/reg. no. and date | DK/EP 2101789, 20141231 | | Publication date | 20090923 | | Priority no. and date | US 855583 P, 20061030 | | EP pub. no. and date |
EP 2101789 20090923 | | Effective date | | | Applicant/owner | Geron Corporation, 149 Commonwealth Drive
Menlo Park, CA 94025, US | | Applicant ref. no. | P21303DKEP | | Inventor | GO, Ning, 3480 Cowper Court
Palo Alto, CA 94306, US,
TRESSLER, Robert J., 4675 Clares Street
Capitola, CA 95010, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 31/70 (2006.01) | | Title | Kombineret telomerasehæmer og gemcitabin til behandling af kræft | | Int. application no. | US2007022850 | | Int. publication no. | WO2008054711 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
